Narrow search
Showing 1 - 10 of 194
Cover Image
Regional differences of standardised mortality rates for ischemic heart diseases in the Slovak Republic for the period 1996-2013 in the context of income inequality
Gavurová, Beáta; Vagašová, Tatiana - In: Health economics review 6 (2016) 21, pp. 1-12
Background: The aim of paper is to analyse the development of standardised mortality rates for ischemic heart diseases … % of national median), S80/S20 and their effect on mortality. Methods: Using data from the Slovak mortality database 1996 … population across regions and over time. To examine the relationships between income indicators and standardised mortality rates …
Persistent link: https://www.econbiz.de/10011585144
Cover Image
Potential gains in life expectancy by eliminating deaths from cardiovascular diseases and diabetes mellitus in the working life ages among Slovak population
Gavurova, Beata; Vagasova, Tatiana - In: Health economics review 8 (2018) 16, pp. 1-8
Background: In recent years, high mortality from cardiovascular diseases (chronic ischemic heart disease, acute … prolonged. Since the mortality of population during working period has higher importance in terms of economic consequences of … entire life span and working life-time. Methods: Data are obtained from the National Health Information Center mortality …
Persistent link: https://www.econbiz.de/10011896539
Cover Image
Cardiovascular drug shortages in Lebanon : a broken heart
Khattar, Georges; Hallit, Jennifer; El Chamieh, Carolla; … - In: Health economics review 12 (2022) 1, pp. 1-2
For nearly 3 years now, Lebanon has been assailed by compounded crises. With the economic instability, the coronavirus pandemic, and the explosion of the Beirut Port on August 4, 2020; the fragile Lebanese healthcare system has found itself at massive risk of a catastrophic public health crisis...
Persistent link: https://www.econbiz.de/10013198765
Cover Image
Out-of-pocket expenditure on community healthcare services at end-of-life among decedents from cardiovascular disease in six European countries and Israel
Aviad, Tur Sinai; Bentur, Netta - In: Health economics review 13 (2023) 1, pp. 1-13
Objectives Most people who develop chronic diseases, including cardiovascular disease (CVD), live in their homes in the community in their last year of life. Since cost-sharing is common in most countries, including those with univer‑ sal health insurance, these people incur out of pocket...
Persistent link: https://www.econbiz.de/10014500464
Cover Image
Who gets a mammogram amongst European women aged 50-69 years?
Wuebker, Ansgar - In: Health economics review 2 (2012) 6, pp. 1-13
On the basis of the Survey of Health, Ageing, and Retirement (SHARE), we analyse the determinants of who engages in mammography screening focusing on European women aged 50-69 years. A special emphasis is put on the measurement error of subjective life expectancy and on the measurement and...
Persistent link: https://www.econbiz.de/10009621116
Cover Image
Balance billing: the patients’ perspective
Kifmann, Mathias; Scheuer, Florian - In: Health economics review 1 (2011) 14, pp. 1-14
We study the effects of "balance billing", i.e., allowing physicians to charge a fee from patients in addition to the fee paid by Medicare. First, we show that on pure efficiency grounds the optimal Medicare fee under balance billing is zero. An active Medicare policy thus can only be justified...
Persistent link: https://www.econbiz.de/10009503927
Cover Image
The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany
Dintsios, C. M.; Beinhauer, I. - In: Health economics review 10 (2020) 7, pp. 1-25
Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price negotiations after early benefit assessment between pharmaceutical companies and the German National Association of Statutory Health Insurance Funds. The analysis was conducted for...
Persistent link: https://www.econbiz.de/10012291135
Cover Image
Implementing personalized medicine with asymmetric information on prevalence rates
Antoñanzas Villar, Fernando; Juárez-Castelló, Carmelo A. - In: Health economics review 6 (2016) 35, pp. 1-8
Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions between pharmaceutical firms and healthcare...
Persistent link: https://www.econbiz.de/10011586604
Cover Image
Does patient behaviour drive physicians to practice defensive medicine? : evidence from a video experiment
Daniels, Lotte; Marneffe, Wim - In: Health economics review 13 (2023) 1, pp. 1-13
Objective By manipulating patients' critical attitude in a video experiment, we examined whether physicians are more intended to perform defensive acts because of a higher perceived liability risk in Belgium. Methods We assigned 85 practicing gynaecologists/obstetricians and orthopaedists...
Persistent link: https://www.econbiz.de/10014500517
Cover Image
Examining proximity to death and health care expenditure by disease : a Bayesian-based descriptive statistical analysis from the National Health Insurance database in Japan
Hiramatsu, Yuji; Ide, Hiroo; Tsuchiya, Atsuko; Furui, Yuji - In: Health economics review 12 (2022) 1, pp. 1-19
Background: Japan is one of the Organization for Economic Co-operation and Development (OECD) countries where population aging and increasing health care expenditures (HCE) are urgent issues. Recent studies have identified factors other than age, such as proximity to death and morbidity, as...
Persistent link: https://www.econbiz.de/10012804399